Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Finished Goods (2016 - 2025)

Bio Key International's Finished Goods history spans 12 years, with the latest figure at $3.6 million for Q3 2025.

  • For Q3 2025, Finished Goods fell 14.57% year-over-year to $3.6 million; the TTM value through Sep 2025 reached $3.6 million, down 14.57%, while the annual FY2024 figure was $4.1 million, 6.28% down from the prior year.
  • Finished Goods for Q3 2025 was $3.6 million at Bio Key International, down from $3.8 million in the prior quarter.
  • Across five years, Finished Goods topped out at $4.9 million in Q1 2022 and bottomed at $494322.0 in Q1 2021.
  • The 5-year median for Finished Goods is $4.4 million (2023), against an average of $4.1 million.
  • The largest annual shift saw Finished Goods soared 2069.86% in 2021 before it fell 14.57% in 2025.
  • A 5-year view of Finished Goods shows it stood at $4.8 million in 2021, then decreased by 0.7% to $4.8 million in 2022, then dropped by 8.22% to $4.4 million in 2023, then fell by 6.28% to $4.1 million in 2024, then decreased by 12.03% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Finished Goods are $3.6 million (Q3 2025), $3.8 million (Q2 2025), and $4.1 million (Q1 2025).